Hormonal
Real-world users of semaglutide (Wegovy) for weight management rarely follow recommended dose titration protocols, with the majority stopping at or below 1.0 mg rather than reaching the target 2.4 mg dose evaluated in clinical trials.
If you are using Wegovy, know that most people do not reach the maximum 2.4 mg dose. Many stop at 1.0 mg due to side effects or cost. This does not mean the drug isn't working for you, but it may mean your weight loss potential is lower than what is seen in clinical trials. Discuss your dose with your provider to see if escalation is appropriate for your tolerance and financial situation.
Only 13% reached the maximum dose of 2.4 mg by their 5th prescription... Overall, 10% followed the treatment guidelines of increasing the dose every four weeks... 33-48% continued with the 1.0 mg dosage from the fourth prescription onwards.
Why this rating
Large population-based cohort study (n=110,748) using national registries, minimizing selection bias, though it lacks direct anthropometric outcome data.
Source
Real-World Use of Semaglutide for Weight Management: Patient Characteristics and Dose Titration—A Danish Cohort Study
Louise Ladebo et al. · Diabetes Care · 2024
DOI 10.2337/dc24-1082
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →